Immunic, Inc. (IMUX)
Immunic Market Cap : 111.01M for Nov. 20, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2026 | 111.01M |
| November 19, 2026 | 117.36M |
| November 18, 2026 | 119.42M |
| November 17, 2026 | 116.41M |
| November 16, 2026 | 114.82M |
| November 13, 2026 | 119.42M |
| November 12, 2026 | 123.71M |
| November 11, 2026 | 128.95M |
| November 10, 2026 | 127.68M |
| November 09, 2026 | 108.61M |
| November 06, 2026 | 105.74M |
| November 05, 2026 | 99.88M |
| November 04, 2026 | 108.34M |
| November 03, 2026 | 103.70M |
| November 02, 2026 | 100.15M |
| October 30, 2026 | 102.47M |
| October 29, 2026 | 106.36M |
| October 28, 2026 | 108.88M |
| October 27, 2026 | 103.83M |
| October 26, 2026 | 99.33M |
| October 23, 2026 | 101.11M |
| October 22, 2026 | 98.51M |
| October 21, 2026 | 102.06M |
| October 20, 2026 | 101.11M |
| October 19, 2026 | 95.38M |
| Date | Value |
|---|---|
| October 16, 2026 | 95.10M |
| October 15, 2026 | 96.88M |
| October 14, 2026 | 90.87M |
| October 13, 2026 | 94.01M |
| October 12, 2026 | 108.47M |
| October 09, 2026 | 111.75M |
| October 08, 2026 | 103.15M |
| October 07, 2026 | 104.11M |
| October 06, 2026 | 106.70M |
| October 05, 2026 | 110.11M |
| October 02, 2026 | 108.61M |
| October 01, 2026 | 117.89M |
| September 30, 2026 | 126.89M |
| September 29, 2026 | 121.57M |
| September 28, 2026 | 129.76M |
| September 25, 2026 | 127.51M |
| September 24, 2026 | 127.17M |
| September 23, 2026 | 127.85M |
| September 22, 2026 | 147.91M |
| September 21, 2026 | 147.77M |
| September 18, 2026 | 144.90M |
| September 17, 2026 | 141.22M |
| September 16, 2026 | 138.08M |
| September 15, 2026 | 141.49M |
| September 14, 2026 | 153.23M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.956B |
| Alnylam Pharmaceuticals, Inc. | 19.25B |
| Anika Therapeutics, Inc. | 177.20M |
| Savara, Inc. | 875.58M |
| Arrowhead Pharmaceuticals, Inc. | 5.845B |
Market Cap Related Metrics
| Price to Book Value | 1.062 |
| Price | 6.99 |
| Earnings Yield | -64.02% |